SEC Insider Transactions from LIN SUE-JEAN.

Last updated: 2026-03-14 11:13 UTC | Total transactions: 9

LIN Sue-Jean, a director at Arcutis Biotherapeutics ($ARQT), made one open market sale of common shares in the last year, totaling about $778 thousand. Her most recent sale occurred on November 24, 2025. Among 11,678 insiders with sales, her activity ranks 5,478th by value, well below the average of $8.6 million across roughly 6.4 transactions per insider. She reported no open market purchases.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Nov. 24, 2025 Arcutis Biotherapeutics, Inc. $ARQT LIN SUE-JEAN Director M Stock Option (right to buy) 7220 $0.00 5,000.0000 132,885,000 59.08% 0.01%
Nov. 24, 2025 Arcutis Biotherapeutics, Inc. $ARQT LIN SUE-JEAN Director M Common Stock 18052 $8.63 44,787.0000 132,885,000 67.52% 0.01%
Nov. 24, 2025 Arcutis Biotherapeutics, Inc. $ARQT LIN SUE-JEAN Director M Common Stock 7220 $7.51 52,007.0000 132,885,000 16.12% 0.01%
Nov. 24, 2025 Arcutis Biotherapeutics, Inc. $ARQT LIN SUE-JEAN Director S Common Stock 25272 $30.78 26,735.0000 132,885,000 48.59% 0.02%
Nov. 24, 2025 Arcutis Biotherapeutics, Inc. $ARQT LIN SUE-JEAN Director M Stock Option (right to buy) 18052 $0.00 9,000.0000 132,885,000 66.73% 0.01%
June 12, 2025 Arcutis Biotherapeutics, Inc. $ARQT LIN SUE-JEAN Director A Stock Option (right to buy) 20568 $0.00 20,568.0000 120,957,633 9999.99% 0.02%
June 12, 2025 Arcutis Biotherapeutics, Inc. $ARQT LIN SUE-JEAN Director A Common Stock 7609 $0.00 26,735.0000 120,957,633 39.78% 0.01%
June 14, 2024 Arcutis Biotherapeutics, Inc. $ARQT LIN SUE-JEAN Director A Common Stock 10139 $0.00 19,126.0000 69,305,487 112.82% 0.01%
June 14, 2024 Arcutis Biotherapeutics, Inc. $ARQT LIN SUE-JEAN Director A Stock Option (right to buy) 27052 $0.00 27,052.0000 69,305,487 9999.99% 0.04%